Casual Conversations #32 Minor Cannabinoids
In this episode of 'Casual Conversations' presented by the Association of Cannabinoid Specialists, moderator Christine Goedhart, PhD steers a panel discussion with clinicians Jordan Tishler, MD, Sandra Carrillo, MD, and Suraj Tandon, MD. They discuss various minor cannabinoids beyond the well-known THC and CBD, focusing on their clinical uses and research.
Dr. Carrillo highlights Cannabigerol (CBG) for anxiety treatment, citing preliminary but promising results. Dr. Tandon concurs, noting the growing interest in CBG despite limited human studies. Dr. Tishler discusses Tetrahyrdocannabivarin (THCV) for metabolic syndrome, touching on its impact on cholesterol and glycemic profiles.
The panelists stress the need for more robust research to validate the efficacy and safety of these minor cannabinoids. They call for a balanced approach, cautioning against premature clinical use without adequate evidence.
Casual Conversations is made possible by the generosity of our supporters. Your donation helps us keep these conversations going. Please consider giving today.